SEC charges two former Ariad executives with insider trading
June 27, 2017 at 13:12 PM EDT
The allegations stem from the Cambridge biotech's discussions with the FDA in 2012 and 2013 regarding cancer drug Iclusig.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|